{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:26:12Z","timestamp":1776212772251,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pmed.1003523","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000}}],"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000278","name":"Department for International Development","doi-asserted-by":"publisher","award":["MR\/R015600\/1"],"award-info":[{"award-number":["MR\/R015600\/1"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development","doi-asserted-by":"publisher","award":["MR\/R015600\/1"],"award-info":[{"award-number":["MR\/R015600\/1"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development","doi-asserted-by":"publisher","award":["MR\/R015600\/1"],"award-info":[{"award-number":["MR\/R015600\/1"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development","doi-asserted-by":"publisher","award":["MR\/R015600\/1"],"award-info":[{"award-number":["MR\/R015600\/1"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1157270"],"award-info":[{"award-number":["OPP1157270"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1157270"],"award-info":[{"award-number":["OPP1157270"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1157270"],"award-info":[{"award-number":["OPP1157270"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1157270"],"award-info":[{"award-number":["OPP1157270"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Eliminate Yellow fever Epidemics (EYE) strategy was launched in 2017 in response to the resurgence of yellow fever in Africa and the Americas. The strategy relies on several vaccination activities, including preventive mass vaccination campaigns (PMVCs). However, to what extent PMVCs are associated with a decreased risk of outbreak has not yet been quantified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      We used the self-controlled case series (SCCS) method to assess the association between the occurrence of yellow fever outbreaks and the implementation of PMVCs at the province level in the African endemic region. As all time-invariant confounders are implicitly controlled for in the SCCS method, this method is an alternative to classical cohort or case\u2013control study designs when the risk of residual confounding is high, in particular confounding by indication. The locations and dates of outbreaks were identified from international epidemiological records, and information on PMVCs was provided by coordinators of vaccination activities and international funders. The study sample consisted of provinces that were both affected by an outbreak and targeted for a PMVC between 2005 and 2018. We compared the incidence of outbreaks before and after the implementation of a PMVC. The sensitivity of our estimates to a range of assumptions was explored, and the results of the SCCS method were compared to those obtained through a retrospective cohort study design. We further derived the number of yellow fever outbreaks that have been prevented by PMVCs. The study sample consisted of 33 provinces from 11 African countries. Among these, the first outbreak occurred during the pre-PMVC period in 26 (79%) provinces, and during the post-PMVC period in 7 (21%) provinces. At the province level, the post-PMVC period was associated with an 86% reduction (95% CI 66% to 94%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) in the risk of outbreak as compared to the pre-PMVC period. This negative association between exposure to PMVCs and outbreak was robustly observed across a range of sensitivity analyses, especially when using quantitative estimates of vaccination coverage as an alternative exposure measure, or when varying the observation period. In contrast, the results of the cohort-style analyses were highly sensitive to the choice of covariates included in the model. Based on the SCCS results, we estimated that PMVCs were associated with a 34% (95% CI 22% to 45%) reduction in the number of outbreaks in Africa from 2005 to 2018. A limitation of our study is the fact that it does not account for potential time-varying confounders, such as changing environmental drivers of yellow fever and possibly improved disease surveillance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study, we provide new empirical evidence of the high preventive impact of PMVCs on yellow fever outbreaks. This study illustrates that the SCCS method can be advantageously applied at the population level in order to evaluate a public health intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1003523","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T15:41:07Z","timestamp":1613662867000},"page":"e1003523","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa: A population-level self-controlled case series study"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6462-7185","authenticated-orcid":true,"given":"K\u00e9vin","family":"Jean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaya","family":"Raad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3734-9081","authenticated-orcid":true,"given":"Katy A. M.","family":"Gaythorpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0871-0640","authenticated-orcid":true,"given":"Arran","family":"Hamlet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith E.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3475-3599","authenticated-orcid":true,"given":"Tewodaj","family":"Mengistu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5833-1863","authenticated-orcid":true,"given":"Heather J.","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tini","family":"Garske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounia N.","family":"Hocine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"pmed.1003523.ref001","first-page":"365","article-title":"Yellow fever in Africa and the Americas, 2018","volume":"94","author":"World Health Organization","year":"2019","journal-title":"Wkly Epidemiol Rec"},{"key":"pmed.1003523.ref002","unstructured":"World Health Organization. Emergencies preparedness, response: disease outbreak news\u2014yellow fever. Geneva: World Health Organization; 2020 [cited 2020 Jul 3]. https:\/\/www.who.int\/csr\/don\/archive\/disease\/yellow_fever\/en\/."},{"key":"pmed.1003523.ref003","first-page":"193","article-title":"Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017\u20132026","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"pmed.1003523.ref004","doi-asserted-by":"crossref","first-page":"e1001638","DOI":"10.1371\/journal.pmed.1001638","article-title":"Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data","volume":"11","author":"T Garske","year":"2014","journal-title":"PLoS Med"},{"key":"pmed.1003523.ref005","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2214-109X(18)30024-X","article-title":"Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis","volume":"6","author":"FM Shearer","year":"2018","journal-title":"Lancet Glob Health"},{"key":"pmed.1003523.ref006","doi-asserted-by":"crossref","first-page":"e0008304","DOI":"10.1371\/journal.pntd.0008304","article-title":"Eliminating yellow fever epidemics in Africa: vaccine demand forecast and impact modelling","volume":"14","author":"K Jean","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"pmed.1003523.ref007","unstructured":"World Health Organization Global Malaria Programme. Guidance on temporary malaria control measures in Ebola-affected countries. Geneva: World Health Organization; 2014 [cited 2021 Feb 11]. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/141493\/WHO_HTM_GMP_2014.10_eng.pdf;jsessionid=8F680505C5FC344148A5579ECB07BC40?sequence=1."},{"key":"pmed.1003523.ref008","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1473-3099(15)70124-6","article-title":"Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis","volume":"15","author":"PGT Walker","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"pmed.1003523.ref009","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1473-3099(11)70147-5","article-title":"The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever","volume":"11","author":"ES Jentes","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"pmed.1003523.ref010","doi-asserted-by":"crossref","first-page":"e0006284","DOI":"10.1371\/journal.pntd.0006284","article-title":"The seasonal influence of climate and environment on yellow fever transmission across Africa","volume":"12","author":"A Hamlet","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pmed.1003523.ref011","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"TP Monath","year":"2015","journal-title":"J Clin Virol"},{"key":"pmed.1003523.ref012","doi-asserted-by":"crossref","first-page":"i4515","DOI":"10.1136\/bmj.i4515","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"I Petersen","year":"2016","journal-title":"BMJ"},{"key":"pmed.1003523.ref013","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2307\/2533328","article-title":"Relative incidence estimation from case series for vaccine safety evaluation","volume":"51","author":"CP Farrington","year":"1995","journal-title":"Biometrics"},{"key":"pmed.1003523.ref014","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4269\/ajtmh.16-0401","article-title":"A meta-analysis of serological response associated with yellow fever vaccination","volume":"95","author":"K Jean","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"pmed.1003523.ref015","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"HJ Whitaker","year":"2006","journal-title":"Stat Med"},{"key":"pmed.1003523.ref016","unstructured":"World Health Organization. Weekly epidemiological record (WER). Geneva: World Health Organization; 2021 [cited 2021 Feb 10]. https:\/\/www.who.int\/wer\/en\/."},{"key":"pmed.1003523.ref017","unstructured":"World Health Organization. Emergencies preparedness, response: disease outbreak news (DONs). Geneva: World Health Organization; 2021 [cited 2021 Feb 10]. https:\/\/www.who.int\/csr\/don\/en\/."},{"key":"pmed.1003523.ref018","first-page":"465","article-title":"Yellow fever surveillance and outbreak response: revision of case definitions, October 2010","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"pmed.1003523.ref019","unstructured":"World Health Organization. Emergencies preparedness, response: the yellow fever initiative: an introduction. Geneva: World Health Organization; 2021 [cited 2021 Feb 10]. https:\/\/www.who.int\/csr\/disease\/yellowfev\/introduction\/en\/."},{"key":"pmed.1003523.ref020","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years","volume":"89","author":"E Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"pmed.1003523.ref021","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMp1803433","article-title":"Fractional-dose yellow fever vaccination\u2014advancing the evidence base","volume":"379","author":"K Vannice","year":"2018","journal-title":"N Engl J Med"},{"key":"pmed.1003523.ref022","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.vaccine.2019.01.074","article-title":"POLICI: a web application for visualising and extracting yellow fever vaccination coverage in Africa","volume":"37","author":"A Hamlet","year":"2019","journal-title":"Vaccine"},{"key":"pmed.1003523.ref023","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1541-0420.2012.01795.x","article-title":"A positive event dependence model for self-controlled case series with applications in postmarketing surveillance","volume":"69","author":"SE Simpson","year":"2013","journal-title":"Biometrics"},{"key":"pmed.1003523.ref024","first-page":"381","article-title":"Yellow fever in Africa and the Americas, 2015","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"pmed.1003523.ref025","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/j.1365-2699.2011.02659.x","article-title":"Correlation and process in species distribution models: bridging a dichotomy","volume":"39","author":"CF Dormann","year":"2012","journal-title":"J Biogeogr"},{"key":"pmed.1003523.ref026","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0962280208092342","article-title":"The methodology of self-controlled case series studies","volume":"18","author":"HJ Whitaker","year":"2009","journal-title":"Stat Methods Med Res"},{"key":"pmed.1003523.ref027","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archfami.9.7.617","article-title":"Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma","volume":"9","author":"P Kramarz","year":"2000","journal-title":"Vaccine Safety Datalink Team. Arch Fam Med"},{"key":"pmed.1003523.ref028","doi-asserted-by":"crossref","first-page":"e4388","DOI":"10.1136\/bmj.e4388","article-title":"Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs","volume":"345","author":"IJ Douglas","year":"2012","journal-title":"BMJ"},{"key":"pmed.1003523.ref029","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(99)01239-8","article-title":"Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association","volume":"353","author":"B Taylor","year":"1999","journal-title":"Lancet"},{"key":"pmed.1003523.ref030","unstructured":"World Health Organization. Yellow fever. Geneva: World Health Organization; 2019 [cited 2021 Feb 11]. http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/yellow-fever."},{"key":"pmed.1003523.ref031","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/ele.12904","article-title":"Pathogen spillover during land conversion","volume":"21","author":"CL Faust","year":"2018","journal-title":"Ecol Lett"},{"key":"pmed.1003523.ref032","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13071-019-3515-7","article-title":"Risk factors associated with sustained circulation of six zoonotic arboviruses: a systematic review for selection of surveillance sites in non-endemic areas","volume":"12","author":"HJ Esser","year":"2019","journal-title":"Parasit Vectors"},{"key":"pmed.1003523.ref033","unstructured":"World Health Organization, UNICEF, Gavi, the Vaccine Alliance. A global strategy to eliminate yellow fever epidemics (EYE) 2017\u20132026. 2017. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272408\/9789241513661-eng.pdf."},{"key":"pmed.1003523.ref034","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1377\/hlthaff.2017.0861","article-title":"The equity impact vaccines may have on averting deaths and medical impoverishment in developing countries","volume":"37","author":"AY Chang","year":"2018","journal-title":"Health Aff (Millwood)"},{"key":"pmed.1003523.ref035","article-title":"Estimating the health impact of vaccination against 10 pathogens in 98 low and middle income countries from 2000 to 2030","author":"X Li","year":"2019","journal-title":"medRxiv"},{"key":"pmed.1003523.ref036","unstructured":"World Health Organization. At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF. Geneva: World Health Organization; 22 May 2020 [cited 2020 Jun 9]. https:\/\/www.who.int\/news-room\/detail\/22-05-2020-at-least-80-million-children-under-one-at-risk-of-diseases-such-as-diphtheria-measles-and-polio-as-covid-19-disrupts-routine-vaccination-efforts-warn-gavi-who-and-unicef."}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1003523","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T14:11:54Z","timestamp":1614867114000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003523"}},"subtitle":[],"editor":[{"given":"Rebecca Freeman","family":"Grais","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003523","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.09.20147355","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]}}}